Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alsoKnownAs |
PD-142,505
|
| gptkbp:CASNumber |
154235-83-3
|
| gptkbp:developedBy |
gptkb:Alzheimer's_disease
gptkb:Pfizer |
| gptkbp:effect |
cognitive enhancement in animal models
|
| gptkbp:hasMolecularFormula |
C17H18N2O2S
|
| https://www.w3.org/2000/01/rdf-schema#label |
CI-1008
|
| gptkbp:mechanismOfAction |
5-HT6 receptor antagonist
|
| gptkbp:PubChem_CID |
176870
CHEMBL19009 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational drug
|
| gptkbp:UNII |
6QX8K7E0ZV
|
| gptkbp:usedAs |
nootropic agent
|
| gptkbp:bfsParent |
gptkb:Pregabalin
|
| gptkbp:bfsLayer |
8
|